Avanza Fonder’s CryoPort CYRX Stock Holding History

Avanza Fonder’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Hold	16,785	–	–	0.01%	397
2026 Q1	$139K	Hold	16,785	–	–	﹤0.01%	423
2025 Q4	$161K	Hold	16,785	–	–	﹤0.01%	438
2025 Q3	$159K	Buy	16,785 +5,903	+54%	+$49.7K	﹤0.01%	398
2025 Q2	$81.2K	Buy	10,882 +2,601	+31%	+$16.1K	﹤0.01%	416
2025 Q1	$51K	Hold	8,281	–	–	﹤0.01%	452
2024 Q4	$64.4K	Buy	+8,281	New	+$61.7K	﹤0.01%	434

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Avanza Fonder's CYRX Position: Q2 2026 in Review

Avanza Fonder held its CryoPort (CYRX) position steady in Q2 2026 at 16,785 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #397.

Avanza Fonder first reported a position in CYRX in Q4 2024 and has held it in 7 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Avanza Fonder held 16,785 shares of CryoPort worth $264K as of Q2 2026.
Avanza Fonder left its CryoPort share count unchanged in Q2 2026.
CryoPort made up 0.01% of Avanza Fonder's portfolio in Q2 2026, its #397 holding.
Avanza Fonder first reported a position in CryoPort in Q4 2024 and has held it in 7 quarters since.
184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.